Coronary Heart Disease Clinical Trial
Official title:
Feasibility and Potential Impact of Community Pharmacy Care Including Motivational Interviews on Adherence to Secondary Prevention Medication in Patients With Coronary Heart Diseases
Introduction:
In the United Kingdom(UK), about 838,000 men and 394,000 women have had a myocardial
infarction (MI) and will need secondary prevention medications. Longterm adherence to
secondary prevention therapies remains poor, nonadherence to medication in MI patients
ranges from 13-60%(1). Studies show that approximately one fourth of cardiac patients do not
refill their cardiac medications (2). Strategies to tackle the burden of non adherence could
involve pharmacy care and The New Medicine Service (which is a service provided by community
pharmacists to help patients on long term medications for chronic diseases) with a
motivational interview incorporated as part of the counselling session of a community
pharmacist. Communication of health providers with patients and between health providers
could also be an important strategy to improve adherence.
Cardiovascular disease is high in all ethnic groups as well as in the general population;
however it is the South Asians who have the highest prevalence of coronary heart disease
(CHD) (3). In addition, South Asians develop CHD at a younger age, often before the age of
40 years (3).
Aim of this study:
This study is to investigate the feasibility and potential impact of a pharmacy care
intervention involving motivational interviews and referral to the New Medicine Service in
coronary heart disease patients on adherence to secondary prevention medication and on
outcomes of coronary heart disease.
Method:
The study is designed as a prospective, controlled feasibility/pilot, intervention study.
The study has two phases.
In the intervention phase a total of 200 coronary heart disease patients discharged from the
London Chest Hospital will be enrolled into the study and followed up for one year.
Pharmacies from up to six London Boroughs will be invited to take place in the study.
Pharmacies will be randomised using a table of random numbers into intervention site or
control site. The pharmacists working in the intervention pharmacies will be invited for
training on the delivery of the intervention and on motivational interviewing. The
intervention will be performed by community pharmacists. Recruitment of patients will take
place in the hospital. In the interview phase 20 patients from South Asian backgrounds will
be invited for a telephone interview to study the effect of their beliefs and cultural
backgrounds in regards to their adherence to cardiac medication.
Outcome measures:
The primary outcome measure is self report adherence with coronary artery disease medication
employing a standard validated measure. Secondary outcomes are blood pressure and LDL-C (low
density lipoprotein cholesterol) in addition to data regarding the feasibility of the
intervention.
Analysis:
Both quantitative and qualitative data analysis will be performed.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
| Completed |
NCT05088291 -
Application of a New X-ray Protective Device in Coronary Interventional Therapy
|
||
| Completed |
NCT03076801 -
Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?
|
N/A | |
| Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
| Not yet recruiting |
NCT04995159 -
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System
|
N/A | |
| Recruiting |
NCT02967718 -
Innovation Research of Differentiation and Treatment Methods Based on CHD Phlegm and Blood Stasis Syndrome
|
N/A | |
| Completed |
NCT02888652 -
Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
|
||
| Completed |
NCT02163044 -
The Hellenic Postprandial Lipemia Study (HPLS)
|
||
| Terminated |
NCT02045134 -
Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery
|
N/A | |
| Active, not recruiting |
NCT02244853 -
Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease
|
N/A | |
| Completed |
NCT02753829 -
Home-based Cardiovascular Rehabilitation, Maintenance Phase, in Subjects With Coronary Artery Disease
|
N/A | |
| Completed |
NCT02440893 -
Understanding the Effect of Metformin on Corus CAD (or ASGES)
|
||
| Terminated |
NCT01906957 -
Cognition and Exercise Training
|
N/A | |
| Completed |
NCT01826552 -
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
|
Phase 4 | |
| Recruiting |
NCT01689688 -
Healing Response to Everolimus-eluting Stent Implantation; Serial Assessment With opticaL Coherence Tomography
|
N/A | |
| Completed |
NCT01779401 -
Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
|
N/A | |
| Recruiting |
NCT01456364 -
Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing
|
Phase 4 | |
| Recruiting |
NCT01462799 -
COR-PRIM: Problem-based Learning (PBL) After Coronary Heart Disease (CHD) - Long-term Evaluation in Primary Care of Self-care
|
N/A | |
| Completed |
NCT01428947 -
Does Coronary Angiography Cause Cognitive Dysfunction?
|
N/A | |
| Completed |
NCT01486030 -
Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
|